MRGPRX2 and hereditary angioedema: Will drugs that block the action of bradykinin help control anaphylactic reactions (3), or will drugs that block mast cell degranulation, such as omalizumab (11) or MRGPRX2 antagonists (12), reduce HAE-C1-INH attacks?